Dear Colleagues,

We are pleased to announce that Current Oncology will be granting the Travel Award to two junior scientists. The applications will be assessed by an Evaluation Committee consisting of senior scholars from the Current Oncology Editorial Board.

This award provides financial support for the winners to attend an international conference in the field of clinical oncology to be held in 2024, in order to hold a presentation, present a poster, or both.

Candidate Requirements:
– Postdoctoral fellows or PhD students;
– Plans to attend an international conference in 2024 (oral presentation or poster).

Required Application Documents:
– Information of the conference the applicant is planning to attend and the abstract that will be submitted;
– Curriculum Vitae and list of publications;
– Justification letter describing the focus of the research (max. 800 words).
– Letter of recommendation from the supervisor, research director, or department head, which also confirms the applicant’s status as a postdoctoral fellow/PhD student.

The winners (two awardees) will each be awarded CHF 500 and a certificate.

Please submit your applications for the Current Oncology 2024 Travel Award online by 31 January 2024. Prizes will be awarded in the middle of April 2024 and announced on the Current Oncology website.

Kind regards,
Current Oncology Editorial Office

Dear Colleagues,

On behalf of the Editor-in-Chief, Prof. Dr. Shahid Ahmed, we wish to acknowledge our reviewers who so generously offer their time to review the papers submitted to Current Oncology by presenting an award to the reviewers who have demonstrated their dedication, professionalism, and timeliness in reviewing manuscripts for Current Oncology.

What are the pre-requisites to be eligible for this award?
– All of the reviewers for Current Oncology in 2023 will be automatically included.

Selection Criteria:
– Number of review reports;
– The quality and timeliness of review reports.

What will the winners receive?
There will be two winners this year, and each will receive the following:
– CHF 500;
– An opportunity to publish a paper free of charge in 2024 after peer review;
– A certificate.

When will the winners be announced?
– The winners will be announced in 31 March 2024 on the journal website.

How can I make myself eligible?
– If you have not yet reviewed papers for Current Oncology, but would like to do so, you can register as a reviewer at the following link:
https://susy.mdpi.com/volunteer/profile/edit.

Kind regards,
Current Oncology Editorial Office

Dear Colleagues,

We are pleased to announce that Current Oncology is now inviting nominations for the Current Oncology 2023 Young Investigator Award. This prize will be given to one young investigator in recognition of their excellence in the field of clinical oncology. All nominations will be assessed by an Evaluation Committee consisting of senior scholars from the Current Oncology Editorial Board.

The Prize
– CHF 2000;
– Option to publish one paper free of charge in Current Oncology after peer review before the end of March 2025;
– An electronic certificate.

Eligibility and Requirements
– Must have completed oncology training and/or received their PhD no more than 10 years prior to 31 March 2024;
– Must have produced ground-breaking research and made a significant contribution to the advancement of clinical oncology;
– Candidates must be nominated by senior scientists/researchers.

List of Documents for Nomination
– Detailed Curriculum Vitae, including an updated publication list and a list of the researcher’s own research grants;
– Scanned copy of doctorate certificate;
– Signed nomination letters from two established senior scientists (at least one must be at professor or clinical professor rank).

Schedule
Open for nomination: 1 June 2023
Nomination deadline: 31 December 2023
Winner announcement: 31 March 2024

How to Submit Nominations?
The nominations must be submitted online.

Contact
Ms. Linnea Ban
Marketing Assistant
Email: [email protected]

Kind regards,
Current Oncology Editorial Office

Dear Colleagues,

As Editor-in-Chief of Current Oncology, I am pleased to announce the winner of the Current Oncology 2023 Travel Award. The award has been granted to Dr. Eleonora Lai, a postdoctoral research fellow at the University Hospital and University of Cagliari, Italy; and Dr. Antonio D’Alessio, a clinical research fellow at Imperial College London, UK.

As the awardees, they will each receive an honorarium of CHF 500 and an electronic certificate.

With so many high-quality applicants, the evaluation process and final decision were incredibly challenging. We would like to thank all the applicants for submitting their diverse and fascinating range of research topics. On behalf of the assessment committee, I would also like to take this opportunity to congratulate the winners on their accomplishments.

Prof. Dr. Sharlene Gill
Editor-in-Chief, Current Oncology

Dear Colleagues,

We are pleased to announce the winners of the Current Oncology 2022 Outstanding Reviewer Award. The Current Oncology Editorial Board and Editorial Team would like to gratefully acknowledge the time and energy dedicated by reviewers in checking the manuscripts submitted to Current Oncology. It is due to their efforts that the high quality of the journal and quick turnaround are maintained.

Dr. Ravi Ramjeesingh
Nova Scotia Cancer Centre and Dalhousie University, Halifax, Canada
Research Interests: pancreatic cancer; hepatocellular carcinoma; cholangio-carcinoma; translational research; real world evidence

Dr. Makoto Endo
Kyushu University, Fukuoka, Japan
Research Interests: sarcoma; bone and soft tissue tumor; bone metastasis; surgery; chemotherapy; translational research

The Prize for Each Winner:
— CHF 500;
— An opportunity to publish a paper free of charge in Current Oncology in 2023 after peer review;
— A certificate.

Kind regards,
Current Oncology Editorial Office

Dear Colleagues,

We are pleased to announce that the winner of the Current Oncology 2022 Young Investigator Award is Dr. Bishal Gyawali.

Dr. Bishal Gyawali is an Associate Professor in the Department of Oncology at Queen’s University, Kingston, Canada. Dr. Bishal Gyawali’s research interests are cancer policy, global oncology, regulatory policy, surrogate endpoints, and quality of life. Dr. Bishal Gyawali received his PhD in 2017 and has an outstanding publication record, comprising 157 peer-reviewed publications in internationally recognized journals. Dr. Bishal Gyawali’s Scopus scientific citations number is 15815 and his Hirsch index is 26. Furthermore, he is a member of the WHO Drug Policy Committee, ASCO Health Equity and Outcomes Committee, ESMO Global Policy Committee, and ESMO-Magnitude of Clinical Benefit Scale Working Group.

Dr. Bishal Gyawali is clearly a rising star in the field of clinical oncology. Please join us in congratulating the awardee for his outstanding achievements.

As the awardee, Dr. Bishal Gyawali will receive an honorarium of CHF 2000, an electronic certificate, and the opportunity to publish one paper free of charge in Current Oncology after peer review before 31 December 2023.

We would like to thank all the nominators from various fields of study for their participation and all the Award Committee Members for their evaluation of the many excellent nominations.

Prof. Dr. Sharlene Gill
Editor-in-Chief, Current Oncology

Dear Colleagues,

We are pleased to announce the winners of the Current Oncology 2022 Travel Award after careful evaluation by the Evaluation Committee.

Dr. Sneha Sethi, a Post-Doctoral Fellow from Adelaide Dental School, University of Adelaide

Dr. Xiyin Wang, a Ph.D. student from the Indiana University School of Medicine are the winners of the awards.

Each of the winners will receive 500 Swiss Francs to support them in attending an international conference in the field of clinical oncology practice.

With so many high-quality applicants, the evaluation process and final decision were challenging. We would like to thank all the applicants for submitting their diverse and fascinating range of research topics and encourage all to participate in the next Current Oncology Travel Awards. On behalf of the assessment committee, we would also like to congratulate the winners on their accomplishments.

Kind regards,
Current Oncology Editorial Office

Dear Colleagues,

We are pleased to announce the winners of the Current Oncology 2021 Outstanding Reviewer Award. The Current Oncology Editorial Board and Editorial Team would like to gratefully acknowledge the time and energy dedicated by reviewers in checking the manuscripts submitted to Current Oncology. It is due to their efforts that the high quality and quick turnaround of the journal have been maintained. The following two reviewers have been selected on the basis of the number, quality, and timeliness of their review reports (in no particular order):

Prof. Dr. Margaret Fitch
Bloomberg Faculty of Nursing, University of Toronto, Toronto, Ontario, Canada
Research Interests: supportive care; cancer care; palliative care; psychosocial oncology; oncology nursing; survivorship; clinical nursing research

Dr. Caroline Mariano
BC Cancer Agency, Vancouver, BC, Canada
Department of Medicine, University of British Columbia, Vancouver, BC, Canada
Research Interests: geriatric (aged); educational program; program evaluation; pharmacoepidemiology; geriatric/oncology; dementia; drug therapy

Each winner will receive a prize of CHF 500, a certificate, and a chance to publish a paper in Current Oncology free of charge in 2022.

Kind regards,
Prof. Dr. Sharlene Gill
Editor-in-Chief, Current Oncology

Dear Colleagues,

We are pleased to announce that the winner of the Current Oncology 2021 Young Investigator Award is Dr. Matteo Lambertini.

Dr. Lambertini is an assistant professor and consultant for medical oncology at the IRCCS Policlinico San Martino Hospital—the University of Genova in Genova, Italy. He is mainly focused on the care of breast cancer patients and is deeply involved in breast cancer research. Dr. Lambertini received his doctoral degree in medical science in 2018 and has an outstanding publication record, comprising 197 peer-reviewed publications in internationally recognized journals. Dr. Lambertini’s Scopus scientific citations number is 3423, and his Hirsch index is 31. He is also a member of the guideline group for fertility preservation in cancer patients for the European Society for Medical Oncology (ESMO), the European Society of Human Reproduction and Embriology (ESHRE), and the Italian Association of Medical Oncology (AIOM).

He is clearly a rising star in the field of clinical breast oncology. Please join us in congratulating the awardee, Dr. Matteo Lambertini, for his outstanding achievements.

As the awardee, Dr. Lambertini will receive a prize of CHF 2000, the opportunity to publish a paper free of charge in Current Oncology before 31 December 2022 after peer review, and an electronic certificate.

We would like to thank all the nominators and nominees for their participation and all the Award Committee members for their careful evaluation of the many excellent nominations.

Best regards,
Current Oncology Editorial Office